Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 2/20 | 0.77 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.77 |
| ▸ | APP | P05067 | 1/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.62 |
| ▸ | MAOB | P27338 | 2/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 4/20 | 0.58 |
| ▸ | BACE1 | P56817 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.54 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30384783 | 0.98 | SLC5A1 (0.80) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL4883627 | 0.98 | SLC5A1 (0.80) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL30384339 | 0.98 | SLC5A1 (0.80) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL13657210 | 0.98 | SLC5A1 (0.80) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL15681494 | 0.94 | SLC5A1 (0.75) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL25234616 | 0.93 | SLC5A1 (0.70) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL17237771 | 0.93 | SLC5A1 (0.70) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL1727986 | 0.93 | SLC5A1 (0.72) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL30383800 | 0.93 | SLC5A1 (0.72) | SLC5A1SLC5A2APPABCG2MAOB | |
| SCHEMBL1727983 | 0.93 | SLC5A1 (0.72) | SLC5A1SLC5A2APPABCG2MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | SLC5A1 4485/4885SLC5A2 4756/4885APP 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.